{"gene":"PPARGC1A","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1999,"finding":"PGC-1α stimulates mitochondrial biogenesis and respiration in muscle cells by inducing NRF-1 and NRF-2 gene expression, and by directly binding to and coactivating NRF-1 on the promoter of mitochondrial transcription factor A (mtTFA), a direct regulator of mitochondrial DNA replication/transcription. PGC-1α also induces UCP-2 expression.","method":"Overexpression in muscle cells, reporter/promoter assays, direct binding/coactivation experiments, mitochondrial function assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (gene expression, promoter binding, functional mitochondrial assays), foundational paper replicated extensively","pmids":["10412986"],"is_preprint":false},{"year":1999,"finding":"Human PPARGC1A encodes a 91-kDa protein with 94% amino acid identity to the mouse ortholog, spans ~67 kb with 13 exons, maps to chromosome 4p15.1, and is expressed in heart, skeletal muscle, kidney, liver, brain, pancreas, and perirenal adipose tissue.","method":"cDNA cloning, genomic organization analysis, Northern blotting, chromosomal mapping","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct molecular characterization of gene structure and tissue expression","pmids":["10585775"],"is_preprint":false},{"year":2005,"finding":"SIRT1 interacts with PGC-1α and deacetylates it at specific lysine residues in an NAD+-dependent manner. SIRT1-mediated deacetylation of PGC-1α induces gluconeogenic genes and hepatic glucose output, but does not regulate PGC-1α effects on mitochondrial genes. Pyruvate-induced fasting signals upregulate SIRT1 protein in liver, which then modulates PGC-1α activity.","method":"Co-immunoprecipitation, in vitro deacetylation assays, adenoviral gain/loss-of-function, hepatic glucose output measurement, gene expression analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reconstitution of deacetylation in vitro, reciprocal interactions confirmed, multiple orthogonal methods, widely replicated","pmids":["15744310"],"is_preprint":false},{"year":2003,"finding":"PGC-1α directly activates CYP7A1 (cholesterol 7α-hydroxylase) gene transcription in hepatic cells, increasing bile acid biosynthesis. PGC-1α activates the CYP7A1 promoter in transient transfection assays, and is co-induced with CYP7A1 in livers of fasted and streptozotocin-diabetic mice.","method":"Adenoviral overexpression in HepG2 cells, transient transfection/promoter assays, bile acid biosynthesis measurement, in vivo mouse models","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — promoter assay plus in vivo corroboration, multiple methods in one study","pmids":["14522988"],"is_preprint":false},{"year":2010,"finding":"PGC-1α promotes peroxisomal remodeling and biogenesis in brown adipose tissue in response to thermogenic stimuli. Ectopic PGC-1α expression recapitulates peroxisomal expansion in vitro and in vivo, and β-adrenergic stimulation of PGC-1α−/− cells shows blunted induction of peroxisomal gene expression. This occurs through a PPARα-independent mechanism.","method":"PGC-1α overexpression, PGC-1α knockout cells, β-adrenergic stimulation, peroxisomal gene expression analysis, organelle imaging","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function in vitro and in vivo, multiple orthogonal methods in one study","pmids":["21059926"],"is_preprint":false},{"year":2012,"finding":"PGC-1α expression in muscle stimulates increased expression of FNDC5, a membrane protein cleaved and secreted as irisin. Irisin acts on white adipose cells to stimulate UCP1 expression and a brown-fat-like thermogenic program. Irisin is induced with exercise in mice and humans and increases energy expenditure.","method":"Transgenic mouse overexpression, cell culture experiments, in vivo irisin treatment, gene expression analysis, metabolic measurement","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo and in vitro, multiple methods, widely replicated and cited","pmids":["22237023"],"is_preprint":false},{"year":2013,"finding":"In the hippocampus, neuronal FNDC5 gene expression is regulated by PGC-1α; Pgc1a−/− mice show reduced Fndc5 expression in the brain. Forced FNDC5 expression in cortical neurons increases Bdnf expression, and peripheral delivery of FNDC5 via adenoviral vectors elevates blood irisin and induces BDNF expression in the hippocampus.","method":"Pgc1a knockout mice, primary neuron cultures, adenoviral overexpression, RNAi knockdown, gene expression analysis","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function knockout, gain-of-function in vitro and in vivo, multiple orthogonal methods","pmids":["24120943"],"is_preprint":false},{"year":2014,"finding":"IRF4 is a transcriptional partner of PGC-1α in adipocytes. IRF4 interacts with PGC-1α and together they drive UCP1 expression. Cold, β-agonists, or forced PGC-1α expression are unable to induce thermogenic gene expression in the absence of IRF4. IRF4 also induces PGC-1α and PRDM16 expression.","method":"Co-immunoprecipitation, IRF4 knockout (UCP1+ cell-specific), IRF4 overexpression, gene expression, energy expenditure measurement, cold tolerance assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, tissue-specific KO and OE, multiple functional assays","pmids":["24995979"],"is_preprint":false},{"year":2009,"finding":"SIRT1 and AMPK directly affect PGC-1α activity through deacetylation and phosphorylation, respectively, acting as an energy-sensing network to control cellular energy expenditure.","method":"Transgenic mouse models, phosphorylation and deacetylation assays, metabolic measurements (review synthesizing experimental findings)","journal":"Current opinion in lipidology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — synthesizes findings from multiple labs with in vivo genetic models, but this paper is primarily a review","pmids":["19276888"],"is_preprint":false},{"year":2009,"finding":"PGC-1α and PGC-1β control mitochondrial density in neurons (cortical, midbrain, and cerebellar granule) in an additive and independent manner. Overexpression of SIRT1 deacetylase or suppression of GCN5 acetyltransferase activates PGC-1α transcriptional activity and increases mitochondrial density specifically through PGC-1α (not PGC-1β), as SIRT1 overexpression was ineffective when PGC-1α was suppressed by shRNA.","method":"Neuronal overexpression and shRNA knockdown, SIRT1 overexpression, GCN5 suppression, mitochondrial density measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — shRNA epistasis, gain-of-function, multiple neuron subtypes tested; single lab","pmids":["19542216"],"is_preprint":false},{"year":2001,"finding":"PGC-1α interacts with components of the splicing machinery, suggesting a role in coordinating transcription and RNA splicing. PGC-1α also regulates multiple nuclear receptors beyond PPARγ and acts as a versatile coactivator.","method":"Protein interaction studies, biochemical assays (review synthesizing experimental findings)","journal":"Trends in endocrinology and metabolism: TEM","confidence":"Low","confidence_rationale":"Tier 3 / Weak — review paper; splicing interaction not directly demonstrated in this abstract","pmids":["11551810"],"is_preprint":false},{"year":2002,"finding":"PGC-1α (and PGC-1β) directly interact with ERRγ (estrogen receptor-related receptor gamma) and potently augment its transcriptional activation. The constitutive AF-2 domain of ERRγ is required for this synergistic enhancement, and an additional amino-terminal activation function specific to ERRγ2 isoform was identified for PGC-1α.","method":"In vitro direct interaction assays, mammalian cell transfection, receptor truncation analysis, reporter assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vitro interaction plus functional reporter assays with domain mapping; single lab","pmids":["12470660"],"is_preprint":false},{"year":2011,"finding":"ATGL-mediated lipolysis generates lipid ligands for PPAR activation. ATGL deficiency in mice decreases PGC-1α and PGC-1β expression in heart, leading to severely disrupted mitochondrial substrate oxidation and lethal cardiomyopathy. Pharmacological PPAR-α agonist treatment of ATGL-deficient mice completely reverses mitochondrial defects, restores heart function, and prevents death.","method":"ATGL knockout mice, PPAR-α agonist treatment, mitochondrial function assays, gene expression analysis, cardiac function measurement","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with pharmacological rescue, in vivo with defined molecular mechanism, multiple functional readouts","pmids":["21857651"],"is_preprint":false},{"year":2012,"finding":"PGC-1α controls extrasynaptic NMDAR (NMDАР_EX) activity in neurons. Knockdown of endogenous PGC-1α increased NMDAR_EX activity and vulnerability to excitotoxic insults in rat cortical neurons. Exogenous PGC-1α expression reduced NMDAR_EX currents without affecting synaptic NMDAR activity. Mutant Huntingtin (mHtt)-mediated suppression of PGC-1α expression and increased NMDAR_EX activity were nonadditive, consistent with a common mechanism.","method":"RNAi knockdown, overexpression in primary neurons, electrophysiology (NMDAR current measurement), excitotoxicity assays, epistasis experiments with mHtt","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal gain/loss-of-function, electrophysiology, genetic epistasis; single lab but multiple orthogonal approaches","pmids":["22593067"],"is_preprint":false},{"year":2012,"finding":"PGC-1α regulates VEGFA expression in retinal cells and is required for normal retinal vessel development and for pathological neovascularization. PGC-1α−/− mice show reduced early retinal vascular outgrowth and reduced capillary density. In oxygen-induced retinopathy, PGC-1α is induced in the inner nuclear layer and PGC-1α−/− mice are protected against pathological neovascularization, with decreased VEGFA expression.","method":"PGC-1α knockout mice, oxygen-induced retinopathy model, VEGFA expression analysis, retinal vascular morphometry","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — PGC-1α KO with defined vascular phenotype and VEGFA mechanistic link, two disease models","pmids":["23141926"],"is_preprint":false},{"year":2015,"finding":"EWS (Ewing sarcoma protein) stabilizes PGC-1α protein by preventing its ubiquitination and proteasomal degradation. Loss of EWS leads to increased expression of E3 ubiquitin ligase FBXW7 and rapid degradation of PGC-1α. Depletion of FBXW7 in EWS-null cells restores PGC-1α expression and mitochondrial density.","method":"EWS knockout cells and mice, ubiquitination assays, proteasome inhibitor experiments, FBXW7 knockdown, mitochondrial density measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ubiquitination assays, genetic epistasis (FBXW7 depletion rescues PGC-1α), in vivo corroboration; single lab","pmids":["25918410"],"is_preprint":false},{"year":2016,"finding":"Endothelial PGC-1α promotes eNOS expression and activity to protect against vascular dysfunction. Endothelial-specific PGC-1α knockout mice are sensitized to endothelial dysfunction and hypertension in response to angiotensin II, while transgenic overexpression is protective. The orphan nuclear receptor ERRα is required to coordinate PGC-1α-induced eNOS expression.","method":"Endothelial-specific KO and TG mice, angiotensin II treatment, eNOS inhibitor experiments, eNOS KO mice, vascular function assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — tissue-specific KO and TG, pharmacological and genetic epistasis with eNOS and ERRα; multiple orthogonal approaches","pmids":["27910955"],"is_preprint":false},{"year":2017,"finding":"The Notch target gene Hes1 directly binds to the regulatory region of PGC-1α (shown by ChIP), suppressing its expression and causing fatty acid oxidation defects and kidney fibrosis. PGC-1α overexpression in tubular cells restores mitochondrial content and reverses the fatty acid oxidation defect induced by Notch overexpression.","method":"Chromatin immunoprecipitation (ChIP), transgenic mouse overexpression, Notch1 transgenic mice, gene expression analysis, mitochondrial content measurement","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — ChIP defines direct Hes1 binding to PGC-1α promoter, genetic rescue experiment in vivo","pmids":["28751525"],"is_preprint":false},{"year":2017,"finding":"A fraction of cellular PGC-1α localizes to the nucleolus and associates with ribosomal DNA upon activation, boosting recruitment of RNA polymerase I and UBF to the rDNA promoter and inducing RNA polymerase I transcription. This links ribosomal biogenesis to mitochondrial biogenesis.","method":"PGC-1α subcellular fractionation/localization, ChIP on rDNA promoter (RNA Pol I, UBF), cell culture and mouse models, analysis in human subjects and Huntington's disease samples","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and localization data, functional transcription assay; single lab","pmids":["28819135"],"is_preprint":false},{"year":2018,"finding":"PGC-1α interacts with ERRα and recruits it to the ERRα response element in the proximal MPC1 (mitochondrial pyruvate carrier 1) promoter, activating MPC1 transcription. MPC1 is required for PGC-1α-induced pyruvate-dependent mitochondrial oxygen consumption, as the MPC inhibitor UK5099 blocks this effect.","method":"PGC-1α overexpression and siRNA knockdown, reporter assays with ERRα response element, Co-IP, mitochondrial oxygen consumption with pharmacological MPC inhibitor","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter reporter, Co-IP, pharmacological epistasis; single lab","pmids":["29669911"],"is_preprint":false},{"year":2018,"finding":"Mutant p53 binds and regulates PGC-1α to enhance tumor cell migration and metastasis. This regulation is markedly impacted by the codon 72 polymorphism (Pro72Arg): tumor cells with the R72 variant of mutant p53 show increased PGC-1α function, greatly increased mitochondrial function, and increased metastatic capability.","method":"Co-immunoprecipitation (mutant p53–PGC-1α), migration/metastasis assays, mitochondrial function assays, in vivo models","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishes binding, functional assays confirm consequence; single lab","pmids":["29463573"],"is_preprint":false},{"year":2019,"finding":"PGC-1α determines the relative ratio of IRS1 and IRS2 in hepatocytes: it drives IRS2 expression downstream of glucagon/cAMP/CREB signaling while simultaneously reducing IRS1 expression, thereby modulating insulin receptor signaling via AKT. This IRS2 induction is CREB-dependent and is essential for insulin-mediated suppression of gluconeogenesis.","method":"Gain- and loss-of-function in primary mouse hepatocytes, gene/protein expression, ex vivo glucose production, in vivo overexpression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal gain/loss-of-function, ex vivo and in vivo; single lab, multiple methods","pmids":["30770439"],"is_preprint":false},{"year":2019,"finding":"PGC-1α upregulates autophagy in vascular smooth muscle cells via SQSTM1/p62, reducing cellular senescence. SQSTM1 is identified as a direct target of PPARGC1A. ppargc1a-deficient VSMCs show reduced autophagosome number, reduced SQSTM1 expression, and increased senescence; these effects are phenocopied by SQSTM1 deficiency.","method":"ppargc1a knockout VSMCs, adenoviral PPARGC1A overexpression, autophagy inhibitors, siRNA (SQSTM1, ATG5), electron microscopy, SA-β-gal senescence assay","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO, siRNA epistasis, multiple autophagy readouts; single lab","pmids":["31441382"],"is_preprint":false},{"year":2019,"finding":"PGC-1α promotes autophagy in fibroblasts to drive TGFβ-induced myofibroblast differentiation and collagen release. Fibroblast-specific PGC-1α knockout in mice prevents bleomycin- and constitutively active TGFβR1-induced skin fibrosis. Pharmacological inhibition of PGC-1α by SR18292 induces regression of pre-established fibrosis.","method":"Fibroblast-specific KO mice, PGC-1α knockdown in human fibroblasts, two mouse fibrosis models, SR18292 pharmacological inhibition, autophagy reporter studies","journal":"Annals of the rheumatic diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO, pharmacological inhibition, two independent disease models, multiple orthogonal methods","pmids":["32482644"],"is_preprint":false},{"year":2020,"finding":"PGC-1α isoform 4 (PGC-1α4) uniquely enhances expression of anti-apoptotic gene programs and attenuates hepatocyte apoptosis in response to TNFα or LPS. In contrast, canonical PGC-1α1 decreases inflammatory gene networks but does not prevent hepatocyte death. The isoforms have distinct yet complementary roles.","method":"Primary mouse hepatocyte gain- and loss-of-function, microarray analysis, apoptosis measurement, TNFα/LPS treatment, in vivo models","journal":"Molecular metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific gain/loss-of-function, multiple functional readouts; single lab","pmids":["32180561"],"is_preprint":false},{"year":2021,"finding":"Microglial PGC-1α promotes autophagy and mitophagy through ULK1 (as revealed by ChIP-Seq showing PGC-1α binding sites, including at ULK1 targets) and interacts with ERRα to induce ULK1 expression. This reduces NLRP3 activation and neuroinflammation after ischemic stroke. Pharmacological inhibition or knockdown of ULK1 abolishes the neuroprotective effects of PGC-1α.","method":"Microglia-specific PGC-1α transgenic mice, MCAO model, ChIP-Seq, ULK1 pharmacological inhibition and siRNA knockdown, NLRP3/cytokine measurement, autophagy/mitophagy assays","journal":"Genome medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-Seq, genetic and pharmacological epistasis with ULK1; single lab","pmids":["33771213"],"is_preprint":false},{"year":2021,"finding":"PGC-1/PPAR signaling active in vivo but not in pluripotent stem cell-derived cardiomyocytes mediates cardiomyocyte maturation. Mosaic gene deletion reveals this signaling regulates maturation through YAP1 and SF3B2 as previously unrecognized downstream proteins.","method":"Single-cell transcriptomics, mosaic gene deletion, gene regulatory network analysis, single cardiomyocyte isolation from neonatal to adult hearts","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mosaic KO with single-cell transcriptomic phenotyping; single lab, novel downstream partners identified","pmids":["33712605"],"is_preprint":false},{"year":2018,"finding":"PGC-1α, together with nuclear receptor ERRα, dose-dependently enhances ALT2 (alanine aminotransferase 2) promoter activity in skeletal muscle cells, increasing alanine production. PGC-1α knockdown reduces ALT2 gene expression, and PGC-1α/ERRα complex regulates alanine metabolism during fasting.","method":"PGC-1α overexpression and knockdown in C2C12 myoblasts, reporter assay of ALT2 promoter, alanine measurement in cells and medium","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with defined ERR element, gain/loss-of-function, functional metabolite measurement; single lab","pmids":["29315328"],"is_preprint":false},{"year":2019,"finding":"The PGC-1α/PPARβ axis is a crucial mediator of Ucp3 (uncoupling protein 3) expression in skeletal muscle cells via transactivation of a distal PPAR response element in the Ucp3 promoter, as revealed by quantitative ChIP. Ucp3 is shown to be essential for PGC-1α-induced oxidative capacity.","method":"ChIP on Ucp3 promoter PPAR response element, PGC-1α overexpression, siRNA/knockdown of PPARβ and UCP3, oxidative capacity measurement","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — ChIP identifies direct promoter binding, functional epistasis with UCP3; single lab","pmids":["31228206"],"is_preprint":false},{"year":2018,"finding":"PGC-1α and PGC-1β increase protein synthesis in C2C12 myotubes via ERRα, independently of Akt/mTOR signaling. Suppression of ERRα attenuates PGC-1α/β-induced protein synthesis and myotube diameter increases, while PI3K and mTOR inhibitors do not block this effect.","method":"PGC-1α/β overexpression in C2C12, PI3K/mTOR inhibitors, ERRα siRNA knockdown, protein synthesis measurement, myotube diameter measurement","journal":"Frontiers in physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic epistasis, functional protein synthesis measurement; single lab","pmids":["30356878"],"is_preprint":false},{"year":2020,"finding":"In zebrafish, ppargc1a is essential for ciliogenesis in nodal, mono-, and multiciliated cells and for renal tubule ciliated cell fate specification during embryogenesis. This function depends on prostaglandin signaling: ppargc1a-deficient animals show reduced ptgs1 (prostaglandin-endoperoxide synthase 1) expression, and ciliogenesis and renal MCC fate are rescued by PGE2 treatment or ptgs1 overexpression.","method":"Zebrafish ppargc1a knockdown/knockout, PGE2 rescue, ptgs1 knockdown and overexpression, cilia imaging, renal MCC fate analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO, pharmacological rescue, genetic epistasis (ptgs1), multiple ciliogenesis readouts; single lab, zebrafish model","pmids":["33176142"],"is_preprint":false},{"year":2023,"finding":"PGC-1α, together with ERRα, regulates mitochondrial translation in skeletal muscle. An age-related impairment in mitochondrial translation is observed in sarcopenic muscle, and exercise (a potent PGC-1α inducer) rectifies this impairment. PGC-1α with ERRα coordinates expression of nuclear- and mitochondrial-encoded proteins for supercomplex formation.","method":"Mouse skeletal muscle aging model, exercise intervention, PGC-1α transgenic/knockout models, mitochondrial translation assays, ERRα interaction studies","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic models plus exercise intervention, mitochondrial translation readout; single lab","pmids":["37639610"],"is_preprint":false},{"year":2006,"finding":"FOXO1 is neither required nor sufficient for PGC-1α stimulation of G6Pase-luciferase fusion gene expression in cells, indicating that the transcriptional interaction between FOXO1 and PGC-1α in gluconeogenesis is indirect (NEGATIVE finding contradicting the proposal that PGC-1α acts directly through FOXO1).","method":"Transfection reporter assays in cells, G6Pase-luciferase reporter, FOXO1 gain/loss-of-function","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct reporter assay with FOXO1 KO and OE; single lab, single method but clearly negative result","pmids":["17024043"],"is_preprint":false}],"current_model":"PGC-1α (PPARGC1A) is a transcriptional coactivator that coordinates mitochondrial biogenesis and energy metabolism by directly binding and coactivating nuclear transcription factors including NRF-1, NRF-2, ERRα, ERRγ, PPARα, PPARβ, and HNF4α on target gene promoters; its activity is dynamically regulated by post-translational modifications including SIRT1-mediated NAD+-dependent deacetylation at specific lysines (activating gluconeogenic but not mitochondrial programs) and AMPK-mediated phosphorylation, as well as by FBXW7-dependent ubiquitination and proteasomal degradation controlled by EWS; it drives diverse downstream programs including FNDC5/irisin secretion (linking muscle exercise to adipose browning and hippocampal BDNF), VEGFA-dependent angiogenesis, MPC1-dependent mitochondrial pyruvate import, UCP3 via a PPARβ-dependent promoter element, ribosomal biogenesis via nucleolar RNA Pol I co-recruitment, and prostaglandin-dependent ciliogenesis, while also modulating NMDAR extrasynaptic activity in neurons, autophagy/mitophagy through ULK1-ERRα, and hepatic IRS1/IRS2 ratio to control insulin sensitivity."},"narrative":{"mechanistic_narrative":"PPARGC1A (PGC-1α) is a transcriptional coactivator that orchestrates mitochondrial biogenesis and the broader cellular energy-metabolism program by inducing and directly coactivating nuclear transcription factors on target promoters [PMID:10412986]. It drives the NRF-1/NRF-2 → mtTFA axis to stimulate mitochondrial DNA replication and respiration in muscle [PMID:10412986], and it acts through the orphan nuclear receptor ERRα as a recurrent partner to activate diverse metabolic targets including the mitochondrial pyruvate carrier MPC1, alanine aminotransferase ALT2, endothelial eNOS, and mitochondrial translation/supercomplex programs [PMID:29669911, PMID:29315328, PMID:27910955, PMID:37639610]; it also enhances ERRγ transactivation via the receptor's AF-2 domain [PMID:12470660]. Through PPARβ it transactivates a distal PPAR response element in the Ucp3 promoter to set oxidative capacity [PMID:31228206], and it supports peroxisomal biogenesis in brown fat and hepatic gluconeogenic and bile-acid (CYP7A1) programs [PMID:21059926, PMID:14522988]. PGC-1α activity is set by an energy-sensing post-translational network: SIRT1 deacetylates it in an NAD+-dependent manner to selectively activate gluconeogenic (but not mitochondrial) genes, while protein abundance is controlled by EWS-dependent suppression of FBXW7-mediated ubiquitination and proteasomal degradation [PMID:15744310, PMID:25918410]. Beyond core metabolism, PGC-1α couples tissue physiology to its transcriptional outputs: it induces muscle FNDC5/irisin to drive adipose browning and, in hippocampus, BDNF expression [PMID:22237023, PMID:24120943], regulates VEGFA-dependent retinal angiogenesis [PMID:23141926], promotes autophagy/mitophagy through SQSTM1 and the ULK1-ERRα axis [PMID:31441382, PMID:33771213], and controls extrasynaptic NMDAR activity and neuronal mitochondrial density [PMID:22593067, PMID:19542216]. Its expression is itself repressed by the Notch effector Hes1, linking it to fatty-acid-oxidation defects and kidney fibrosis [PMID:28751525].","teleology":[{"year":1999,"claim":"Established the founding mechanism by which PGC-1α builds mitochondria — defining it as a coactivator that both induces and directly binds nuclear respiratory factors to drive the mtTFA-dependent mitochondrial gene program.","evidence":"Overexpression in muscle cells with promoter/binding assays and mitochondrial function readouts","pmids":["10412986"],"confidence":"High","gaps":["Did not map the post-translational signals that switch the coactivator on","Tissue-specific selectivity of NRF coactivation not addressed"]},{"year":1999,"claim":"Defined the human gene structure, chromosomal location, and broad tissue expression, framing PGC-1α as a metabolically active coactivator across energy-demanding organs.","evidence":"cDNA cloning, genomic organization, Northern blotting, chromosomal mapping","pmids":["10585775"],"confidence":"High","gaps":["No functional or mechanistic data","Isoform diversity not characterized"]},{"year":2002,"claim":"Showed PGC-1α directly partners with the ERR family, identifying ERRγ as a coactivation target and mapping the receptor AF-2 domain requirement — a partnership that recurs across later metabolic programs.","evidence":"In vitro interaction, transfection reporter assays, receptor truncation mapping","pmids":["12470660"],"confidence":"Medium","gaps":["Endogenous gene targets of the PGC-1α–ERRγ pair not defined","Single-lab in vitro context"]},{"year":2003,"claim":"Extended PGC-1α function into hepatic lipid/cholesterol catabolism by showing direct activation of the CYP7A1 promoter and bile-acid biosynthesis under fasting/diabetic conditions.","evidence":"Adenoviral overexpression in HepG2, promoter assays, bile-acid measurement, mouse models","pmids":["14522988"],"confidence":"High","gaps":["Direct transcription-factor intermediary on the CYP7A1 promoter not pinned down"]},{"year":2005,"claim":"Revealed how nutrient status tunes coactivator activity — SIRT1 NAD+-dependent deacetylation selectively activates the gluconeogenic but not the mitochondrial branch of PGC-1α output.","evidence":"Co-IP, in vitro deacetylation, adenoviral gain/loss-of-function, hepatic glucose output","pmids":["15744310"],"confidence":"High","gaps":["Acetyl-lysine residues conferring program selectivity not fully resolved","Counterbalancing acetyltransferase identity not addressed here"]},{"year":2006,"claim":"Tested whether PGC-1α drives gluconeogenesis through FOXO1 and showed FOXO1 is neither necessary nor sufficient, redefining their cooperation as indirect.","evidence":"G6Pase-luciferase reporter assays with FOXO1 gain/loss-of-function","pmids":["17024043"],"confidence":"Medium","gaps":["The actual direct factor mediating gluconeogenic activation left open","Single reporter system"]},{"year":2009,"claim":"Demonstrated PGC-1α controls neuronal mitochondrial density and is the specific effector of SIRT1/GCN5 acetylation signaling in neurons, distinguishing its role from PGC-1β.","evidence":"Neuronal overexpression/shRNA epistasis, SIRT1 OE, GCN5 suppression, mitochondrial density","pmids":["19542216"],"confidence":"Medium","gaps":["Downstream neuronal transcription factors not mapped","Single lab"]},{"year":2011,"claim":"Placed PGC-1α downstream of lipolysis-derived PPAR ligands in cardiac substrate oxidation, where its loss contributes to lethal cardiomyopathy rescued by PPARα agonism.","evidence":"ATGL knockout mice with PPARα agonist rescue, mitochondrial and cardiac function assays","pmids":["21857651"],"confidence":"High","gaps":["Direct contribution of PGC-1α versus PGC-1β to the rescue not separated"]},{"year":2012,"claim":"Connected muscle PGC-1α to systemic endocrine signaling by identifying the FNDC5/irisin myokine that drives white-adipose browning and energy expenditure.","evidence":"Transgenic mice, cell culture, in vivo irisin treatment, metabolic measurement","pmids":["22237023"],"confidence":"High","gaps":["The adipocyte irisin receptor not identified in this work"]},{"year":2012,"claim":"Expanded PGC-1α function to angiogenesis, showing it drives VEGFA expression required for retinal vessel development and pathological neovascularization.","evidence":"PGC-1α KO mice, oxygen-induced retinopathy, VEGFA expression, vascular morphometry","pmids":["23141926"],"confidence":"High","gaps":["Transcription factor partner on the VEGFA promoter not defined"]},{"year":2012,"claim":"Identified a neuroprotective role distinct from bioenergetics — PGC-1α restrains extrasynaptic NMDAR activity and excitotoxicity, with shared mechanism in Huntingtin pathology.","evidence":"RNAi/overexpression in primary neurons, electrophysiology, excitotoxicity and mHtt epistasis","pmids":["22593067"],"confidence":"High","gaps":["Molecular effector linking PGC-1α to NMDAR surface activity unknown"]},{"year":2013,"claim":"Extended the FNDC5/irisin axis to the brain, showing PGC-1α-dependent neuronal FNDC5 drives hippocampal BDNF expression.","evidence":"Pgc1a KO mice, primary neuron cultures, adenoviral OE, RNAi, gene expression","pmids":["24120943"],"confidence":"High","gaps":["Mechanism by which FNDC5 induces BDNF not resolved"]},{"year":2014,"claim":"Identified IRF4 as a required transcriptional partner for the thermogenic UCP1 program, showing PGC-1α cannot drive thermogenesis without it.","evidence":"Reciprocal Co-IP, tissue-specific IRF4 KO/OE, energy expenditure and cold tolerance","pmids":["24995979"],"confidence":"High","gaps":["Structural basis of the IRF4–PGC-1α interaction not defined"]},{"year":2015,"claim":"Established proteostatic control of PGC-1α abundance — EWS stabilizes the protein by suppressing FBXW7-mediated ubiquitination and degradation.","evidence":"EWS KO cells/mice, ubiquitination and proteasome assays, FBXW7 knockdown rescue","pmids":["25918410"],"confidence":"High","gaps":["Degradation-targeting phosphodegron on PGC-1α not mapped here"]},{"year":2016,"claim":"Defined an endothelial protective program in which ERRα-dependent PGC-1α drives eNOS expression to guard against hypertension.","evidence":"Endothelial-specific KO/TG mice, angiotensin II, eNOS and ERRα genetic/pharmacologic epistasis","pmids":["27910955"],"confidence":"High","gaps":["Direct ERRα binding site on the eNOS gene not shown"]},{"year":2017,"claim":"Showed PGC-1α expression is directly repressed by the Notch effector Hes1, mechanistically linking its suppression to fatty-acid-oxidation defects and kidney fibrosis.","evidence":"ChIP for Hes1 on the PGC-1α regulatory region, Notch1 transgenic mice, rescue by PGC-1α OE","pmids":["28751525"],"confidence":"High","gaps":["Cofactors mediating Hes1 repression not identified"]},{"year":2017,"claim":"Revealed a non-canonical nucleolar role for PGC-1α — it associates with rDNA and boosts RNA Pol I/UBF recruitment, coupling ribosomal to mitochondrial biogenesis.","evidence":"Subcellular fractionation, rDNA ChIP for Pol I and UBF, cell and mouse models","pmids":["28819135"],"confidence":"Medium","gaps":["Signal directing PGC-1α to the nucleolus unknown","Single lab"]},{"year":2018,"claim":"Mapped a direct PGC-1α–ERRα mechanism for mitochondrial pyruvate import via activation of the MPC1 promoter, required for pyruvate-dependent respiration.","evidence":"OE/siRNA, ERRα-response-element reporter, Co-IP, oxygen consumption with MPC inhibitor","pmids":["29669911"],"confidence":"Medium","gaps":["Endogenous ERRα occupancy at the MPC1 locus not shown by ChIP","Single lab"]},{"year":2018,"claim":"Showed the PGC-1α–ERRα pair controls amino-acid metabolism by transactivating the ALT2 promoter to drive fasting alanine production.","evidence":"OE/knockdown in C2C12, ALT2 promoter reporter, alanine measurement","pmids":["29315328"],"confidence":"Medium","gaps":["In vivo confirmation of the muscle alanine program limited","Single lab"]},{"year":2018,"claim":"Demonstrated PGC-1α/β increase muscle protein synthesis and myotube growth through ERRα, independently of the Akt/mTOR pathway.","evidence":"C2C12 OE with PI3K/mTOR inhibitors and ERRα siRNA, protein-synthesis and diameter readouts","pmids":["30356878"],"confidence":"Medium","gaps":["Direct translational targets downstream of ERRα not defined","Single lab"]},{"year":2018,"claim":"Linked mutant p53 to PGC-1α in cancer, showing the codon 72 R72 variant enhances PGC-1α-driven mitochondrial function and metastatic capacity.","evidence":"Co-IP, migration/metastasis and mitochondrial assays, in vivo models","pmids":["29463573"],"confidence":"Medium","gaps":["Mechanism of mutant-p53 modulation of PGC-1α activity not detailed","Single lab"]},{"year":2019,"claim":"Defined the PGC-1α/PPARβ axis as the direct driver of Ucp3 via a distal PPAR response element, with UCP3 essential for PGC-1α-induced oxidative capacity.","evidence":"Quantitative ChIP on the Ucp3 promoter, OE, PPARβ/UCP3 knockdown, oxidative capacity","pmids":["31228206"],"confidence":"Medium","gaps":["Mechanism by which UCP3 supports oxidative capacity not resolved","Single lab"]},{"year":2019,"claim":"Showed PGC-1α sets the hepatic IRS1/IRS2 ratio downstream of glucagon/cAMP/CREB to control insulin-mediated suppression of gluconeogenesis.","evidence":"Reciprocal gain/loss-of-function in hepatocytes, ex vivo glucose production, in vivo OE","pmids":["30770439"],"confidence":"Medium","gaps":["Direct CREB/PGC-1α occupancy at the IRS2 locus not shown","Single lab"]},{"year":2019,"claim":"Identified SQSTM1/p62 as a direct PGC-1α target driving vascular smooth muscle autophagy and limiting senescence.","evidence":"ppargc1a KO VSMCs, adenoviral OE, autophagy inhibitors, SQSTM1/ATG5 siRNA, EM, SA-β-gal","pmids":["31441382"],"confidence":"Medium","gaps":["Direct promoter binding to SQSTM1 not demonstrated by ChIP","Single lab"]},{"year":2019,"claim":"Showed PGC-1α promotes fibroblast autophagy to enable TGFβ-driven myofibroblast differentiation and fibrosis, with pharmacological inhibition reversing established fibrosis.","evidence":"Fibroblast-specific KO mice, two fibrosis models, SR18292 inhibition, autophagy reporters","pmids":["32482644"],"confidence":"High","gaps":["Direct autophagy gene targets in fibroblasts not enumerated"]},{"year":2020,"claim":"Distinguished PGC-1α isoform functions, showing isoform 4 uniquely drives anti-apoptotic programs in hepatocytes while canonical PGC-1α1 suppresses inflammatory networks.","evidence":"Isoform-specific gain/loss-of-function in hepatocytes, microarray, apoptosis assays, TNFα/LPS","pmids":["32180561"],"confidence":"Medium","gaps":["Transcription factor partners distinguishing isoform-specific programs not defined","Single lab"]},{"year":2020,"claim":"Revealed a developmental role in zebrafish, where ppargc1a drives ciliogenesis and ciliated-cell fate through prostaglandin (ptgs1/PGE2) signaling.","evidence":"Zebrafish KO with PGE2 and ptgs1 rescue/epistasis, cilia imaging, renal MCC fate","pmids":["33176142"],"confidence":"Medium","gaps":["Mammalian conservation of the ciliogenic role not tested here","Single lab, zebrafish model"]},{"year":2021,"claim":"Defined a microglial PGC-1α–ERRα–ULK1 axis promoting autophagy/mitophagy that limits NLRP3 inflammasome activation after ischemic stroke.","evidence":"Microglia-specific TG mice, MCAO, ChIP-Seq, ULK1 inhibition/knockdown, NLRP3/autophagy readouts","pmids":["33771213"],"confidence":"Medium","gaps":["Direct ERRα-dependent occupancy at ULK1 not isolated from ChIP-Seq","Single lab"]},{"year":2021,"claim":"Implicated PGC-1/PPAR signaling in cardiomyocyte maturation through previously unrecognized downstream proteins YAP1 and SF3B2, active in vivo but not in iPSC-derived cardiomyocytes.","evidence":"Single-cell transcriptomics, mosaic gene deletion, gene regulatory network analysis","pmids":["33712605"],"confidence":"Medium","gaps":["Direct regulatory relationships to YAP1/SF3B2 not biochemically established","Single lab"]},{"year":2023,"claim":"Showed PGC-1α with ERRα coordinates mitochondrial translation and supercomplex assembly, an axis impaired in sarcopenic muscle and restored by exercise.","evidence":"Mouse aging and exercise models, PGC-1α TG/KO, mitochondrial translation assays, ERRα interaction","pmids":["37639610"],"confidence":"Medium","gaps":["Mechanism coupling nuclear coactivation to mitochondrial translation not resolved","Single lab"]},{"year":null,"claim":"How distinct PGC-1α post-translational marks and isoforms are decoded into program-specific transcription factor recruitment — selecting gluconeogenic, mitochondrial, thermogenic, autophagic, or angiogenic outputs in a given cell — remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking specific acetyl/phospho marks to specific transcription-factor partner engagement","Genome-wide direct binding maps across tissues incomplete","Structural basis of coactivator–receptor selectivity unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,3,11,16,17,19,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2,17]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[18]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,2,3,19,27,28]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,11,17,28]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,4,18]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[22,23,25]}],"complexes":[],"partners":["ERRA","ERRG","SIRT1","IRF4","EWS","FBXW7","HES1","TP53"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UBK2","full_name":"Peroxisome proliferator-activated receptor gamma coactivator 1-alpha","aliases":["Ligand effect modulator 6"],"length_aa":798,"mass_kda":91.0,"function":"Transcriptional coactivator for steroid receptors and nuclear receptors (PubMed:10713165, PubMed:20005308, PubMed:21376232, PubMed:28363985, PubMed:32433991). Greatly increases the transcriptional activity of PPARG and thyroid hormone receptor on the uncoupling protein promoter (PubMed:10713165, PubMed:20005308, PubMed:21376232). Can regulate key mitochondrial genes that contribute to the program of adaptive thermogenesis (PubMed:10713165, PubMed:20005308, PubMed:21376232). Plays an essential role in metabolic reprogramming in response to dietary availability through coordination of the expression of a wide array of genes involved in glucose and fatty acid metabolism (PubMed:10713165, PubMed:20005308, PubMed:21376232). Acts as a key regulator of gluconeogenesis: stimulates hepatic gluconeogenesis by increasing the expression of gluconeogenic enzymes, and acting together with FOXO1 to promote the fasting gluconeogenic program (PubMed:16753578, PubMed:23142079). Induces the expression of PERM1 in the skeletal muscle in an ESRRA-dependent manner (PubMed:23836911). Also involved in the integration of the circadian rhythms and energy metabolism (By similarity). Required for oscillatory expression of clock genes, such as BMAL1 and NR1D1, through the coactivation of RORA and RORC, and metabolic genes, such as PDK4 and PEPCK (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UBK2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PPARGC1A","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PPARGC1A","total_profiled":1310},"omim":[{"mim_id":"619030","title":"SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS; SMGMQTL","url":"https://www.omim.org/entry/619030"},{"mim_id":"618802","title":"tRNA-HISTIDINE GUANYLYLTRANSFERASE 1-LIKE PROTEIN; THG1L","url":"https://www.omim.org/entry/618802"},{"mim_id":"617462","title":"PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR-RELATED PROTEIN 1; PPRC1","url":"https://www.omim.org/entry/617462"},{"mim_id":"616241","title":"METEORIN-LIKE PROTEIN; METRNL","url":"https://www.omim.org/entry/616241"},{"mim_id":"615921","title":"PPARGC1- AND ESRR-INDUCED REGULATOR, MUSCLE, 1; PERM1","url":"https://www.omim.org/entry/615921"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"liver","ntpm":41.7}],"url":"https://www.proteinatlas.org/search/PPARGC1A"},"hgnc":{"alias_symbol":["PGC1","PGC1A","PGC-1alpha","PPARAGCIα"],"prev_symbol":["PPARGC1"]},"alphafold":{"accession":"Q9UBK2","domains":[{"cath_id":"3.30.70.330","chopping":"650-760","consensus_level":"high","plddt":83.2723,"start":650,"end":760}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBK2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBK2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBK2-F1-predicted_aligned_error_v6.png","plddt_mean":52.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PPARGC1A","jax_strain_url":"https://www.jax.org/strain/search?query=PPARGC1A"},"sequence":{"accession":"Q9UBK2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBK2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBK2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBK2"}},"corpus_meta":[{"pmid":"22237023","id":"PMC_22237023","title":"A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22237023","citation_count":3781,"is_preprint":false},{"pmid":"10412986","id":"PMC_10412986","title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1.","date":"1999","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/10412986","citation_count":3411,"is_preprint":false},{"pmid":"15744310","id":"PMC_15744310","title":"Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15744310","citation_count":2642,"is_preprint":false},{"pmid":"19276888","id":"PMC_19276888","title":"PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.","date":"2009","source":"Current opinion in lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/19276888","citation_count":1343,"is_preprint":false},{"pmid":"24120943","id":"PMC_24120943","title":"Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway.","date":"2013","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24120943","citation_count":1107,"is_preprint":false},{"pmid":"20933024","id":"PMC_20933024","title":"Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20933024","citation_count":1035,"is_preprint":false},{"pmid":"21289221","id":"PMC_21289221","title":"Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis.","date":"2011","source":"The American journal of clinical nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/21289221","citation_count":1032,"is_preprint":false},{"pmid":"17108241","id":"PMC_17108241","title":"PGC-1alpha: a key regulator of energy metabolism.","date":"2006","source":"Advances in physiology education","url":"https://pubmed.ncbi.nlm.nih.gov/17108241","citation_count":999,"is_preprint":false},{"pmid":"21857651","id":"PMC_21857651","title":"ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1.","date":"2011","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21857651","citation_count":649,"is_preprint":false},{"pmid":"30400212","id":"PMC_30400212","title":"PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30400212","citation_count":378,"is_preprint":false},{"pmid":"22072942","id":"PMC_22072942","title":"Roles of oxidative stress, apoptosis, PGC-1α and mitochondrial biogenesis in cerebral ischemia.","date":"2011","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22072942","citation_count":287,"is_preprint":false},{"pmid":"24995979","id":"PMC_24995979","title":"IRF4 is a key thermogenic transcriptional partner of PGC-1α.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/24995979","citation_count":267,"is_preprint":false},{"pmid":"19542216","id":"PMC_19542216","title":"PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19542216","citation_count":256,"is_preprint":false},{"pmid":"11551810","id":"PMC_11551810","title":"PGC-1, a versatile coactivator.","date":"2001","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/11551810","citation_count":248,"is_preprint":false},{"pmid":"32102312","id":"PMC_32102312","title":"The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases.","date":"2020","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/32102312","citation_count":236,"is_preprint":false},{"pmid":"15711583","id":"PMC_15711583","title":"Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha.","date":"2005","source":"International journal of obesity (2005)","url":"https://pubmed.ncbi.nlm.nih.gov/15711583","citation_count":232,"is_preprint":false},{"pmid":"23347985","id":"PMC_23347985","title":"Regulation of mitochondrial biogenesis and PGC-1α under cellular stress.","date":"2013","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/23347985","citation_count":220,"is_preprint":false},{"pmid":"20401754","id":"PMC_20401754","title":"PGC-1alpha-mediated adaptations in skeletal muscle.","date":"2010","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20401754","citation_count":185,"is_preprint":false},{"pmid":"30518830","id":"PMC_30518830","title":"Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators.","date":"2019","source":"Nature reviews. Gastroenterology & hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/30518830","citation_count":185,"is_preprint":false},{"pmid":"23602910","id":"PMC_23602910","title":"PGC-1α, mitochondrial dysfunction, and Huntington's disease.","date":"2013","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23602910","citation_count":182,"is_preprint":false},{"pmid":"21325336","id":"PMC_21325336","title":"PGC-1 coactivators in the control of energy metabolism.","date":"2011","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/21325336","citation_count":176,"is_preprint":false},{"pmid":"33771213","id":"PMC_33771213","title":"Microglial PGC-1α protects against ischemic brain injury by suppressing neuroinflammation.","date":"2021","source":"Genome medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33771213","citation_count":172,"is_preprint":false},{"pmid":"10585775","id":"PMC_10585775","title":"Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10585775","citation_count":165,"is_preprint":false},{"pmid":"17903321","id":"PMC_17903321","title":"Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1).","date":"2007","source":"Public health nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/17903321","citation_count":162,"is_preprint":false},{"pmid":"31441382","id":"PMC_31441382","title":"SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31441382","citation_count":156,"is_preprint":false},{"pmid":"30906622","id":"PMC_30906622","title":"The metabolic modulator PGC-1α in cancer.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30906622","citation_count":143,"is_preprint":false},{"pmid":"25007880","id":"PMC_25007880","title":"PPARγ and PGC-1α as therapeutic targets in Parkinson's.","date":"2014","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/25007880","citation_count":141,"is_preprint":false},{"pmid":"28751525","id":"PMC_28751525","title":"PGC-1α Protects from Notch-Induced Kidney Fibrosis Development.","date":"2017","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/28751525","citation_count":137,"is_preprint":false},{"pmid":"29388552","id":"PMC_29388552","title":"PGC-1: The Energetic Regulator in Cardiac Metabolism.","date":"2018","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29388552","citation_count":112,"is_preprint":false},{"pmid":"26317511","id":"PMC_26317511","title":"PGC-1α Promoter Methylation in Parkinson's Disease.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26317511","citation_count":106,"is_preprint":false},{"pmid":"30770439","id":"PMC_30770439","title":"PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30770439","citation_count":97,"is_preprint":false},{"pmid":"19446346","id":"PMC_19446346","title":"The biology of PGC-1α and its therapeutic potential.","date":"2009","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/19446346","citation_count":96,"is_preprint":false},{"pmid":"28607951","id":"PMC_28607951","title":"PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors.","date":"2016","source":"Trends in cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28607951","citation_count":96,"is_preprint":false},{"pmid":"22939990","id":"PMC_22939990","title":"PGC-1 proteins and heart failure.","date":"2012","source":"Trends in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22939990","citation_count":95,"is_preprint":false},{"pmid":"15454076","id":"PMC_15454076","title":"PGC-1alpha: turbocharging mitochondria.","date":"2004","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15454076","citation_count":94,"is_preprint":false},{"pmid":"21059926","id":"PMC_21059926","title":"Transcriptional coactivator PGC-1alpha promotes peroxisomal remodeling and biogenesis.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21059926","citation_count":94,"is_preprint":false},{"pmid":"29463573","id":"PMC_29463573","title":"Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/29463573","citation_count":92,"is_preprint":false},{"pmid":"11126248","id":"PMC_11126248","title":"Regulation of adipogenesis and energy balance by PPARgamma and PGC-1.","date":"2000","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/11126248","citation_count":89,"is_preprint":false},{"pmid":"14522988","id":"PMC_14522988","title":"PGC-1alpha activates CYP7A1 and bile acid biosynthesis.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14522988","citation_count":89,"is_preprint":false},{"pmid":"29580918","id":"PMC_29580918","title":"PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders.","date":"2018","source":"Ageing research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/29580918","citation_count":88,"is_preprint":false},{"pmid":"26962700","id":"PMC_26962700","title":"PGC-1α Induces Human RPE Oxidative Metabolism and Antioxidant Capacity.","date":"2016","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/26962700","citation_count":87,"is_preprint":false},{"pmid":"27312223","id":"PMC_27312223","title":"Role of PGC-1α in Vascular Regulation: Implications for Atherosclerosis.","date":"2016","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27312223","citation_count":84,"is_preprint":false},{"pmid":"35427500","id":"PMC_35427500","title":"SnapShot: Regulation and biology of PGC-1α.","date":"2022","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/35427500","citation_count":81,"is_preprint":false},{"pmid":"33712605","id":"PMC_33712605","title":"PGC1/PPAR drive cardiomyocyte maturation at single cell level via YAP1 and SF3B2.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33712605","citation_count":80,"is_preprint":false},{"pmid":"32528825","id":"PMC_32528825","title":"Natural products, PGC-1  , and Duchenne muscular dystrophy.","date":"2020","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/32528825","citation_count":79,"is_preprint":false},{"pmid":"36932115","id":"PMC_36932115","title":"Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.","date":"2023","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/36932115","citation_count":78,"is_preprint":false},{"pmid":"31469445","id":"PMC_31469445","title":"Melatonin/PGC1A/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning.","date":"2019","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/31469445","citation_count":77,"is_preprint":false},{"pmid":"27051562","id":"PMC_27051562","title":"The association between PGC-1α and Alzheimer's disease.","date":"2016","source":"Anatomy & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27051562","citation_count":75,"is_preprint":false},{"pmid":"24428821","id":"PMC_24428821","title":"Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions.","date":"2014","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24428821","citation_count":72,"is_preprint":false},{"pmid":"17828388","id":"PMC_17828388","title":"Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure.","date":"2007","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/17828388","citation_count":70,"is_preprint":false},{"pmid":"23141926","id":"PMC_23141926","title":"PGC-1α regulates normal and pathological angiogenesis in the retina.","date":"2012","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23141926","citation_count":65,"is_preprint":false},{"pmid":"33971494","id":"PMC_33971494","title":"Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways.","date":"2021","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33971494","citation_count":65,"is_preprint":false},{"pmid":"32083094","id":"PMC_32083094","title":"Multiple Levels of PGC-1α Dysregulation in Heart Failure.","date":"2020","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32083094","citation_count":64,"is_preprint":false},{"pmid":"20840068","id":"PMC_20840068","title":"The role of PGC-1α in the pathogenesis of neurodegenerative disorders.","date":"2010","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/20840068","citation_count":62,"is_preprint":false},{"pmid":"33022986","id":"PMC_33022986","title":"PGC-1α in Disease: Recent Renal Insights into a Versatile Metabolic Regulator.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33022986","citation_count":61,"is_preprint":false},{"pmid":"12470660","id":"PMC_12470660","title":"PGC-1 and PERC, coactivators of the estrogen receptor-related receptor gamma.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12470660","citation_count":61,"is_preprint":false},{"pmid":"22593067","id":"PMC_22593067","title":"PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22593067","citation_count":55,"is_preprint":false},{"pmid":"25217629","id":"PMC_25217629","title":"The role of nNOS and PGC-1α in skeletal muscle cells.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25217629","citation_count":51,"is_preprint":false},{"pmid":"32375875","id":"PMC_32375875","title":"Functional effects of muscle PGC-1alpha in aged animals.","date":"2020","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/32375875","citation_count":51,"is_preprint":false},{"pmid":"24258516","id":"PMC_24258516","title":"Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology.","date":"2013","source":"Seminars in immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/24258516","citation_count":51,"is_preprint":false},{"pmid":"17024043","id":"PMC_17024043","title":"Gluconeogenesis: re-evaluating the FOXO1-PGC-1alpha connection.","date":"2006","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17024043","citation_count":51,"is_preprint":false},{"pmid":"33393034","id":"PMC_33393034","title":"SIRT3-Mediated SOD2 and PGC-1α Contribute to Chemoresistance in Colorectal Cancer Cells.","date":"2021","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33393034","citation_count":48,"is_preprint":false},{"pmid":"27022940","id":"PMC_27022940","title":"SIRT1 prevents hyperuricemia via the PGC-1α/PPARγ-ABCG2 pathway.","date":"2016","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/27022940","citation_count":47,"is_preprint":false},{"pmid":"20134150","id":"PMC_20134150","title":"PGC-1α and myokines in the aging muscle - a mini-review.","date":"2010","source":"Gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/20134150","citation_count":46,"is_preprint":false},{"pmid":"30848477","id":"PMC_30848477","title":"Posttranslational regulation of PGC-1α and its implication in cancer metabolism.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30848477","citation_count":45,"is_preprint":false},{"pmid":"27910955","id":"PMC_27910955","title":"PGC-1α dictates endothelial function through regulation of eNOS expression.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27910955","citation_count":45,"is_preprint":false},{"pmid":"31101737","id":"PMC_31101737","title":"Loss of PGC-1α in RPE induces mesenchymal transition and promotes retinal degeneration.","date":"2019","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/31101737","citation_count":44,"is_preprint":false},{"pmid":"32933582","id":"PMC_32933582","title":"Exercise enhances mitochondrial fission and mitophagy to improve myopathy following critical limb ischemia in elderly mice via the PGC1a/FNDC5/irisin pathway.","date":"2020","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/32933582","citation_count":43,"is_preprint":false},{"pmid":"31808750","id":"PMC_31808750","title":"Apolipoprotein E regulates mitochondrial function through the PGC-1α-sirtuin 3 pathway.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31808750","citation_count":41,"is_preprint":false},{"pmid":"31410709","id":"PMC_31410709","title":"Role of PGC-1α in Mitochondrial Quality Control in Neurodegenerative Diseases.","date":"2019","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/31410709","citation_count":40,"is_preprint":false},{"pmid":"28433632","id":"PMC_28433632","title":"Role of microRNA-130b in placental PGC-1α/TFAM mitochondrial biogenesis pathway.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28433632","citation_count":40,"is_preprint":false},{"pmid":"18220593","id":"PMC_18220593","title":"PGC-1alpha and exercise: important partners in combating insulin resistance.","date":"2005","source":"Current diabetes reviews","url":"https://pubmed.ncbi.nlm.nih.gov/18220593","citation_count":38,"is_preprint":false},{"pmid":"32180561","id":"PMC_32180561","title":"PGC-1α isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments.","date":"2020","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32180561","citation_count":37,"is_preprint":false},{"pmid":"35011673","id":"PMC_35011673","title":"Covering the Role of PGC-1α in the Nervous System.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35011673","citation_count":35,"is_preprint":false},{"pmid":"28819135","id":"PMC_28819135","title":"Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington's disease.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28819135","citation_count":35,"is_preprint":false},{"pmid":"32482644","id":"PMC_32482644","title":"PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis.","date":"2020","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32482644","citation_count":34,"is_preprint":false},{"pmid":"29669911","id":"PMC_29669911","title":"MPC1 is essential for PGC-1α-induced mitochondrial respiration and biogenesis.","date":"2018","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/29669911","citation_count":34,"is_preprint":false},{"pmid":"37639610","id":"PMC_37639610","title":"Impaired age-associated mitochondrial translation is mitigated by exercise and PGC-1α.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37639610","citation_count":33,"is_preprint":false},{"pmid":"33925372","id":"PMC_33925372","title":"Role of PGC-1α in the Mitochondrial NAD+ Pool in Metabolic Diseases.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33925372","citation_count":32,"is_preprint":false},{"pmid":"25927001","id":"PMC_25927001","title":"Regulation of PGC-1α Isoform Expression in Skeletal Muscles.","date":"2015","source":"Acta naturae","url":"https://pubmed.ncbi.nlm.nih.gov/25927001","citation_count":32,"is_preprint":false},{"pmid":"25918410","id":"PMC_25918410","title":"Inactivation of EWS reduces PGC-1α protein stability and mitochondrial homeostasis.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25918410","citation_count":31,"is_preprint":false},{"pmid":"29315328","id":"PMC_29315328","title":"PGC-1α regulates alanine metabolism in muscle cells.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29315328","citation_count":30,"is_preprint":false},{"pmid":"33812061","id":"PMC_33812061","title":"PGC1A driven enhanced mitochondrial DNA copy number predicts outcome in pediatric acute myeloid leukemia.","date":"2021","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/33812061","citation_count":30,"is_preprint":false},{"pmid":"35917205","id":"PMC_35917205","title":"PGC-1 alpha regulates mitochondrial biogenesis to ameliorate hypoxia-inhibited cementoblast mineralization.","date":"2022","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35917205","citation_count":30,"is_preprint":false},{"pmid":"28803067","id":"PMC_28803067","title":"PPARGC1A is upregulated and facilitates lung cancer metastasis.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28803067","citation_count":30,"is_preprint":false},{"pmid":"33988807","id":"PMC_33988807","title":"Flavonoids modulate AMPK/PGC-1α and interconnected pathways toward potential neuroprotective activities.","date":"2021","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/33988807","citation_count":28,"is_preprint":false},{"pmid":"29629336","id":"PMC_29629336","title":"Deciphering the Dichotomous Effects of PGC-1α on Tumorigenesis and Metastasis.","date":"2018","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29629336","citation_count":28,"is_preprint":false},{"pmid":"37852548","id":"PMC_37852548","title":"GLIS1 alleviates cell senescence and renal fibrosis through PGC1-α mediated mitochondrial quality control in kidney aging.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37852548","citation_count":28,"is_preprint":false},{"pmid":"31228206","id":"PMC_31228206","title":"Essential role of the PGC-1α/PPARβ axis in Ucp3 gene induction.","date":"2019","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31228206","citation_count":28,"is_preprint":false},{"pmid":"30356878","id":"PMC_30356878","title":"PGC-1α and PGC-1β Increase Protein Synthesis via ERRα in C2C12 Myotubes.","date":"2018","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30356878","citation_count":27,"is_preprint":false},{"pmid":"33176142","id":"PMC_33176142","title":"Ppargc1a Controls Ciliated Cell Development by Regulating Prostaglandin Biosynthesis.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33176142","citation_count":27,"is_preprint":false},{"pmid":"30236862","id":"PMC_30236862","title":"The PPARGC1A locus and CNS-specific PGC-1α isoforms are associated with Parkinson's Disease.","date":"2018","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30236862","citation_count":26,"is_preprint":false},{"pmid":"22678664","id":"PMC_22678664","title":"PGC-1α: a master gene that is hard to master.","date":"2012","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/22678664","citation_count":25,"is_preprint":false},{"pmid":"24057597","id":"PMC_24057597","title":"Genetic models of PGC-1 and glucose metabolism and homeostasis.","date":"2014","source":"Reviews in endocrine & metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24057597","citation_count":25,"is_preprint":false},{"pmid":"31846369","id":"PMC_31846369","title":"Pgc1a is responsible for the sex differences in hepatic Cidec/Fsp27β mRNA expression in hepatic steatosis of mice fed a Western diet.","date":"2019","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31846369","citation_count":25,"is_preprint":false},{"pmid":"28400503","id":"PMC_28400503","title":"PGC-1α and fasting-induced PDH regulation in mouse skeletal muscle.","date":"2017","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/28400503","citation_count":24,"is_preprint":false},{"pmid":"22627493","id":"PMC_22627493","title":"Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.","date":"2012","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/22627493","citation_count":24,"is_preprint":false},{"pmid":"29186342","id":"PMC_29186342","title":"Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism.","date":"2018","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29186342","citation_count":23,"is_preprint":false},{"pmid":"35988807","id":"PMC_35988807","title":"Indole-3-acetic acid improves the hepatic mitochondrial respiration defects by PGC1a up-regulation.","date":"2022","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/35988807","citation_count":23,"is_preprint":false},{"pmid":"25923461","id":"PMC_25923461","title":"IGF2, LEPR, POMC, PPARG, and PPARGC1 gene variants are associated with obesity-related risk phenotypes in Brazilian children and adolescents.","date":"2015","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/25923461","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45594,"output_tokens":8351,"usd":0.131023,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18675,"output_tokens":7441,"usd":0.1397,"stage2_stop_reason":"end_turn"},"total_usd":0.270723,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"PGC-1α stimulates mitochondrial biogenesis and respiration in muscle cells by inducing NRF-1 and NRF-2 gene expression, and by directly binding to and coactivating NRF-1 on the promoter of mitochondrial transcription factor A (mtTFA), a direct regulator of mitochondrial DNA replication/transcription. PGC-1α also induces UCP-2 expression.\",\n      \"method\": \"Overexpression in muscle cells, reporter/promoter assays, direct binding/coactivation experiments, mitochondrial function assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (gene expression, promoter binding, functional mitochondrial assays), foundational paper replicated extensively\",\n      \"pmids\": [\"10412986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human PPARGC1A encodes a 91-kDa protein with 94% amino acid identity to the mouse ortholog, spans ~67 kb with 13 exons, maps to chromosome 4p15.1, and is expressed in heart, skeletal muscle, kidney, liver, brain, pancreas, and perirenal adipose tissue.\",\n      \"method\": \"cDNA cloning, genomic organization analysis, Northern blotting, chromosomal mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct molecular characterization of gene structure and tissue expression\",\n      \"pmids\": [\"10585775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SIRT1 interacts with PGC-1α and deacetylates it at specific lysine residues in an NAD+-dependent manner. SIRT1-mediated deacetylation of PGC-1α induces gluconeogenic genes and hepatic glucose output, but does not regulate PGC-1α effects on mitochondrial genes. Pyruvate-induced fasting signals upregulate SIRT1 protein in liver, which then modulates PGC-1α activity.\",\n      \"method\": \"Co-immunoprecipitation, in vitro deacetylation assays, adenoviral gain/loss-of-function, hepatic glucose output measurement, gene expression analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reconstitution of deacetylation in vitro, reciprocal interactions confirmed, multiple orthogonal methods, widely replicated\",\n      \"pmids\": [\"15744310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PGC-1α directly activates CYP7A1 (cholesterol 7α-hydroxylase) gene transcription in hepatic cells, increasing bile acid biosynthesis. PGC-1α activates the CYP7A1 promoter in transient transfection assays, and is co-induced with CYP7A1 in livers of fasted and streptozotocin-diabetic mice.\",\n      \"method\": \"Adenoviral overexpression in HepG2 cells, transient transfection/promoter assays, bile acid biosynthesis measurement, in vivo mouse models\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — promoter assay plus in vivo corroboration, multiple methods in one study\",\n      \"pmids\": [\"14522988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PGC-1α promotes peroxisomal remodeling and biogenesis in brown adipose tissue in response to thermogenic stimuli. Ectopic PGC-1α expression recapitulates peroxisomal expansion in vitro and in vivo, and β-adrenergic stimulation of PGC-1α−/− cells shows blunted induction of peroxisomal gene expression. This occurs through a PPARα-independent mechanism.\",\n      \"method\": \"PGC-1α overexpression, PGC-1α knockout cells, β-adrenergic stimulation, peroxisomal gene expression analysis, organelle imaging\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function in vitro and in vivo, multiple orthogonal methods in one study\",\n      \"pmids\": [\"21059926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PGC-1α expression in muscle stimulates increased expression of FNDC5, a membrane protein cleaved and secreted as irisin. Irisin acts on white adipose cells to stimulate UCP1 expression and a brown-fat-like thermogenic program. Irisin is induced with exercise in mice and humans and increases energy expenditure.\",\n      \"method\": \"Transgenic mouse overexpression, cell culture experiments, in vivo irisin treatment, gene expression analysis, metabolic measurement\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo and in vitro, multiple methods, widely replicated and cited\",\n      \"pmids\": [\"22237023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In the hippocampus, neuronal FNDC5 gene expression is regulated by PGC-1α; Pgc1a−/− mice show reduced Fndc5 expression in the brain. Forced FNDC5 expression in cortical neurons increases Bdnf expression, and peripheral delivery of FNDC5 via adenoviral vectors elevates blood irisin and induces BDNF expression in the hippocampus.\",\n      \"method\": \"Pgc1a knockout mice, primary neuron cultures, adenoviral overexpression, RNAi knockdown, gene expression analysis\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function knockout, gain-of-function in vitro and in vivo, multiple orthogonal methods\",\n      \"pmids\": [\"24120943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"IRF4 is a transcriptional partner of PGC-1α in adipocytes. IRF4 interacts with PGC-1α and together they drive UCP1 expression. Cold, β-agonists, or forced PGC-1α expression are unable to induce thermogenic gene expression in the absence of IRF4. IRF4 also induces PGC-1α and PRDM16 expression.\",\n      \"method\": \"Co-immunoprecipitation, IRF4 knockout (UCP1+ cell-specific), IRF4 overexpression, gene expression, energy expenditure measurement, cold tolerance assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, tissue-specific KO and OE, multiple functional assays\",\n      \"pmids\": [\"24995979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SIRT1 and AMPK directly affect PGC-1α activity through deacetylation and phosphorylation, respectively, acting as an energy-sensing network to control cellular energy expenditure.\",\n      \"method\": \"Transgenic mouse models, phosphorylation and deacetylation assays, metabolic measurements (review synthesizing experimental findings)\",\n      \"journal\": \"Current opinion in lipidology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — synthesizes findings from multiple labs with in vivo genetic models, but this paper is primarily a review\",\n      \"pmids\": [\"19276888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PGC-1α and PGC-1β control mitochondrial density in neurons (cortical, midbrain, and cerebellar granule) in an additive and independent manner. Overexpression of SIRT1 deacetylase or suppression of GCN5 acetyltransferase activates PGC-1α transcriptional activity and increases mitochondrial density specifically through PGC-1α (not PGC-1β), as SIRT1 overexpression was ineffective when PGC-1α was suppressed by shRNA.\",\n      \"method\": \"Neuronal overexpression and shRNA knockdown, SIRT1 overexpression, GCN5 suppression, mitochondrial density measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — shRNA epistasis, gain-of-function, multiple neuron subtypes tested; single lab\",\n      \"pmids\": [\"19542216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PGC-1α interacts with components of the splicing machinery, suggesting a role in coordinating transcription and RNA splicing. PGC-1α also regulates multiple nuclear receptors beyond PPARγ and acts as a versatile coactivator.\",\n      \"method\": \"Protein interaction studies, biochemical assays (review synthesizing experimental findings)\",\n      \"journal\": \"Trends in endocrinology and metabolism: TEM\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — review paper; splicing interaction not directly demonstrated in this abstract\",\n      \"pmids\": [\"11551810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PGC-1α (and PGC-1β) directly interact with ERRγ (estrogen receptor-related receptor gamma) and potently augment its transcriptional activation. The constitutive AF-2 domain of ERRγ is required for this synergistic enhancement, and an additional amino-terminal activation function specific to ERRγ2 isoform was identified for PGC-1α.\",\n      \"method\": \"In vitro direct interaction assays, mammalian cell transfection, receptor truncation analysis, reporter assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vitro interaction plus functional reporter assays with domain mapping; single lab\",\n      \"pmids\": [\"12470660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ATGL-mediated lipolysis generates lipid ligands for PPAR activation. ATGL deficiency in mice decreases PGC-1α and PGC-1β expression in heart, leading to severely disrupted mitochondrial substrate oxidation and lethal cardiomyopathy. Pharmacological PPAR-α agonist treatment of ATGL-deficient mice completely reverses mitochondrial defects, restores heart function, and prevents death.\",\n      \"method\": \"ATGL knockout mice, PPAR-α agonist treatment, mitochondrial function assays, gene expression analysis, cardiac function measurement\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with pharmacological rescue, in vivo with defined molecular mechanism, multiple functional readouts\",\n      \"pmids\": [\"21857651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PGC-1α controls extrasynaptic NMDAR (NMDАР_EX) activity in neurons. Knockdown of endogenous PGC-1α increased NMDAR_EX activity and vulnerability to excitotoxic insults in rat cortical neurons. Exogenous PGC-1α expression reduced NMDAR_EX currents without affecting synaptic NMDAR activity. Mutant Huntingtin (mHtt)-mediated suppression of PGC-1α expression and increased NMDAR_EX activity were nonadditive, consistent with a common mechanism.\",\n      \"method\": \"RNAi knockdown, overexpression in primary neurons, electrophysiology (NMDAR current measurement), excitotoxicity assays, epistasis experiments with mHtt\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal gain/loss-of-function, electrophysiology, genetic epistasis; single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"22593067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PGC-1α regulates VEGFA expression in retinal cells and is required for normal retinal vessel development and for pathological neovascularization. PGC-1α−/− mice show reduced early retinal vascular outgrowth and reduced capillary density. In oxygen-induced retinopathy, PGC-1α is induced in the inner nuclear layer and PGC-1α−/− mice are protected against pathological neovascularization, with decreased VEGFA expression.\",\n      \"method\": \"PGC-1α knockout mice, oxygen-induced retinopathy model, VEGFA expression analysis, retinal vascular morphometry\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — PGC-1α KO with defined vascular phenotype and VEGFA mechanistic link, two disease models\",\n      \"pmids\": [\"23141926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EWS (Ewing sarcoma protein) stabilizes PGC-1α protein by preventing its ubiquitination and proteasomal degradation. Loss of EWS leads to increased expression of E3 ubiquitin ligase FBXW7 and rapid degradation of PGC-1α. Depletion of FBXW7 in EWS-null cells restores PGC-1α expression and mitochondrial density.\",\n      \"method\": \"EWS knockout cells and mice, ubiquitination assays, proteasome inhibitor experiments, FBXW7 knockdown, mitochondrial density measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ubiquitination assays, genetic epistasis (FBXW7 depletion rescues PGC-1α), in vivo corroboration; single lab\",\n      \"pmids\": [\"25918410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Endothelial PGC-1α promotes eNOS expression and activity to protect against vascular dysfunction. Endothelial-specific PGC-1α knockout mice are sensitized to endothelial dysfunction and hypertension in response to angiotensin II, while transgenic overexpression is protective. The orphan nuclear receptor ERRα is required to coordinate PGC-1α-induced eNOS expression.\",\n      \"method\": \"Endothelial-specific KO and TG mice, angiotensin II treatment, eNOS inhibitor experiments, eNOS KO mice, vascular function assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific KO and TG, pharmacological and genetic epistasis with eNOS and ERRα; multiple orthogonal approaches\",\n      \"pmids\": [\"27910955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The Notch target gene Hes1 directly binds to the regulatory region of PGC-1α (shown by ChIP), suppressing its expression and causing fatty acid oxidation defects and kidney fibrosis. PGC-1α overexpression in tubular cells restores mitochondrial content and reverses the fatty acid oxidation defect induced by Notch overexpression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), transgenic mouse overexpression, Notch1 transgenic mice, gene expression analysis, mitochondrial content measurement\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — ChIP defines direct Hes1 binding to PGC-1α promoter, genetic rescue experiment in vivo\",\n      \"pmids\": [\"28751525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A fraction of cellular PGC-1α localizes to the nucleolus and associates with ribosomal DNA upon activation, boosting recruitment of RNA polymerase I and UBF to the rDNA promoter and inducing RNA polymerase I transcription. This links ribosomal biogenesis to mitochondrial biogenesis.\",\n      \"method\": \"PGC-1α subcellular fractionation/localization, ChIP on rDNA promoter (RNA Pol I, UBF), cell culture and mouse models, analysis in human subjects and Huntington's disease samples\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and localization data, functional transcription assay; single lab\",\n      \"pmids\": [\"28819135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PGC-1α interacts with ERRα and recruits it to the ERRα response element in the proximal MPC1 (mitochondrial pyruvate carrier 1) promoter, activating MPC1 transcription. MPC1 is required for PGC-1α-induced pyruvate-dependent mitochondrial oxygen consumption, as the MPC inhibitor UK5099 blocks this effect.\",\n      \"method\": \"PGC-1α overexpression and siRNA knockdown, reporter assays with ERRα response element, Co-IP, mitochondrial oxygen consumption with pharmacological MPC inhibitor\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter reporter, Co-IP, pharmacological epistasis; single lab\",\n      \"pmids\": [\"29669911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Mutant p53 binds and regulates PGC-1α to enhance tumor cell migration and metastasis. This regulation is markedly impacted by the codon 72 polymorphism (Pro72Arg): tumor cells with the R72 variant of mutant p53 show increased PGC-1α function, greatly increased mitochondrial function, and increased metastatic capability.\",\n      \"method\": \"Co-immunoprecipitation (mutant p53–PGC-1α), migration/metastasis assays, mitochondrial function assays, in vivo models\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishes binding, functional assays confirm consequence; single lab\",\n      \"pmids\": [\"29463573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PGC-1α determines the relative ratio of IRS1 and IRS2 in hepatocytes: it drives IRS2 expression downstream of glucagon/cAMP/CREB signaling while simultaneously reducing IRS1 expression, thereby modulating insulin receptor signaling via AKT. This IRS2 induction is CREB-dependent and is essential for insulin-mediated suppression of gluconeogenesis.\",\n      \"method\": \"Gain- and loss-of-function in primary mouse hepatocytes, gene/protein expression, ex vivo glucose production, in vivo overexpression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal gain/loss-of-function, ex vivo and in vivo; single lab, multiple methods\",\n      \"pmids\": [\"30770439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PGC-1α upregulates autophagy in vascular smooth muscle cells via SQSTM1/p62, reducing cellular senescence. SQSTM1 is identified as a direct target of PPARGC1A. ppargc1a-deficient VSMCs show reduced autophagosome number, reduced SQSTM1 expression, and increased senescence; these effects are phenocopied by SQSTM1 deficiency.\",\n      \"method\": \"ppargc1a knockout VSMCs, adenoviral PPARGC1A overexpression, autophagy inhibitors, siRNA (SQSTM1, ATG5), electron microscopy, SA-β-gal senescence assay\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO, siRNA epistasis, multiple autophagy readouts; single lab\",\n      \"pmids\": [\"31441382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PGC-1α promotes autophagy in fibroblasts to drive TGFβ-induced myofibroblast differentiation and collagen release. Fibroblast-specific PGC-1α knockout in mice prevents bleomycin- and constitutively active TGFβR1-induced skin fibrosis. Pharmacological inhibition of PGC-1α by SR18292 induces regression of pre-established fibrosis.\",\n      \"method\": \"Fibroblast-specific KO mice, PGC-1α knockdown in human fibroblasts, two mouse fibrosis models, SR18292 pharmacological inhibition, autophagy reporter studies\",\n      \"journal\": \"Annals of the rheumatic diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO, pharmacological inhibition, two independent disease models, multiple orthogonal methods\",\n      \"pmids\": [\"32482644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PGC-1α isoform 4 (PGC-1α4) uniquely enhances expression of anti-apoptotic gene programs and attenuates hepatocyte apoptosis in response to TNFα or LPS. In contrast, canonical PGC-1α1 decreases inflammatory gene networks but does not prevent hepatocyte death. The isoforms have distinct yet complementary roles.\",\n      \"method\": \"Primary mouse hepatocyte gain- and loss-of-function, microarray analysis, apoptosis measurement, TNFα/LPS treatment, in vivo models\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific gain/loss-of-function, multiple functional readouts; single lab\",\n      \"pmids\": [\"32180561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Microglial PGC-1α promotes autophagy and mitophagy through ULK1 (as revealed by ChIP-Seq showing PGC-1α binding sites, including at ULK1 targets) and interacts with ERRα to induce ULK1 expression. This reduces NLRP3 activation and neuroinflammation after ischemic stroke. Pharmacological inhibition or knockdown of ULK1 abolishes the neuroprotective effects of PGC-1α.\",\n      \"method\": \"Microglia-specific PGC-1α transgenic mice, MCAO model, ChIP-Seq, ULK1 pharmacological inhibition and siRNA knockdown, NLRP3/cytokine measurement, autophagy/mitophagy assays\",\n      \"journal\": \"Genome medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-Seq, genetic and pharmacological epistasis with ULK1; single lab\",\n      \"pmids\": [\"33771213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PGC-1/PPAR signaling active in vivo but not in pluripotent stem cell-derived cardiomyocytes mediates cardiomyocyte maturation. Mosaic gene deletion reveals this signaling regulates maturation through YAP1 and SF3B2 as previously unrecognized downstream proteins.\",\n      \"method\": \"Single-cell transcriptomics, mosaic gene deletion, gene regulatory network analysis, single cardiomyocyte isolation from neonatal to adult hearts\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mosaic KO with single-cell transcriptomic phenotyping; single lab, novel downstream partners identified\",\n      \"pmids\": [\"33712605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PGC-1α, together with nuclear receptor ERRα, dose-dependently enhances ALT2 (alanine aminotransferase 2) promoter activity in skeletal muscle cells, increasing alanine production. PGC-1α knockdown reduces ALT2 gene expression, and PGC-1α/ERRα complex regulates alanine metabolism during fasting.\",\n      \"method\": \"PGC-1α overexpression and knockdown in C2C12 myoblasts, reporter assay of ALT2 promoter, alanine measurement in cells and medium\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with defined ERR element, gain/loss-of-function, functional metabolite measurement; single lab\",\n      \"pmids\": [\"29315328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The PGC-1α/PPARβ axis is a crucial mediator of Ucp3 (uncoupling protein 3) expression in skeletal muscle cells via transactivation of a distal PPAR response element in the Ucp3 promoter, as revealed by quantitative ChIP. Ucp3 is shown to be essential for PGC-1α-induced oxidative capacity.\",\n      \"method\": \"ChIP on Ucp3 promoter PPAR response element, PGC-1α overexpression, siRNA/knockdown of PPARβ and UCP3, oxidative capacity measurement\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — ChIP identifies direct promoter binding, functional epistasis with UCP3; single lab\",\n      \"pmids\": [\"31228206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PGC-1α and PGC-1β increase protein synthesis in C2C12 myotubes via ERRα, independently of Akt/mTOR signaling. Suppression of ERRα attenuates PGC-1α/β-induced protein synthesis and myotube diameter increases, while PI3K and mTOR inhibitors do not block this effect.\",\n      \"method\": \"PGC-1α/β overexpression in C2C12, PI3K/mTOR inhibitors, ERRα siRNA knockdown, protein synthesis measurement, myotube diameter measurement\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic epistasis, functional protein synthesis measurement; single lab\",\n      \"pmids\": [\"30356878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In zebrafish, ppargc1a is essential for ciliogenesis in nodal, mono-, and multiciliated cells and for renal tubule ciliated cell fate specification during embryogenesis. This function depends on prostaglandin signaling: ppargc1a-deficient animals show reduced ptgs1 (prostaglandin-endoperoxide synthase 1) expression, and ciliogenesis and renal MCC fate are rescued by PGE2 treatment or ptgs1 overexpression.\",\n      \"method\": \"Zebrafish ppargc1a knockdown/knockout, PGE2 rescue, ptgs1 knockdown and overexpression, cilia imaging, renal MCC fate analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO, pharmacological rescue, genetic epistasis (ptgs1), multiple ciliogenesis readouts; single lab, zebrafish model\",\n      \"pmids\": [\"33176142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PGC-1α, together with ERRα, regulates mitochondrial translation in skeletal muscle. An age-related impairment in mitochondrial translation is observed in sarcopenic muscle, and exercise (a potent PGC-1α inducer) rectifies this impairment. PGC-1α with ERRα coordinates expression of nuclear- and mitochondrial-encoded proteins for supercomplex formation.\",\n      \"method\": \"Mouse skeletal muscle aging model, exercise intervention, PGC-1α transgenic/knockout models, mitochondrial translation assays, ERRα interaction studies\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic models plus exercise intervention, mitochondrial translation readout; single lab\",\n      \"pmids\": [\"37639610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FOXO1 is neither required nor sufficient for PGC-1α stimulation of G6Pase-luciferase fusion gene expression in cells, indicating that the transcriptional interaction between FOXO1 and PGC-1α in gluconeogenesis is indirect (NEGATIVE finding contradicting the proposal that PGC-1α acts directly through FOXO1).\",\n      \"method\": \"Transfection reporter assays in cells, G6Pase-luciferase reporter, FOXO1 gain/loss-of-function\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct reporter assay with FOXO1 KO and OE; single lab, single method but clearly negative result\",\n      \"pmids\": [\"17024043\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PGC-1α (PPARGC1A) is a transcriptional coactivator that coordinates mitochondrial biogenesis and energy metabolism by directly binding and coactivating nuclear transcription factors including NRF-1, NRF-2, ERRα, ERRγ, PPARα, PPARβ, and HNF4α on target gene promoters; its activity is dynamically regulated by post-translational modifications including SIRT1-mediated NAD+-dependent deacetylation at specific lysines (activating gluconeogenic but not mitochondrial programs) and AMPK-mediated phosphorylation, as well as by FBXW7-dependent ubiquitination and proteasomal degradation controlled by EWS; it drives diverse downstream programs including FNDC5/irisin secretion (linking muscle exercise to adipose browning and hippocampal BDNF), VEGFA-dependent angiogenesis, MPC1-dependent mitochondrial pyruvate import, UCP3 via a PPARβ-dependent promoter element, ribosomal biogenesis via nucleolar RNA Pol I co-recruitment, and prostaglandin-dependent ciliogenesis, while also modulating NMDAR extrasynaptic activity in neurons, autophagy/mitophagy through ULK1-ERRα, and hepatic IRS1/IRS2 ratio to control insulin sensitivity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PPARGC1A (PGC-1α) is a transcriptional coactivator that orchestrates mitochondrial biogenesis and the broader cellular energy-metabolism program by inducing and directly coactivating nuclear transcription factors on target promoters [#0]. It drives the NRF-1/NRF-2 → mtTFA axis to stimulate mitochondrial DNA replication and respiration in muscle [#0], and it acts through the orphan nuclear receptor ERRα as a recurrent partner to activate diverse metabolic targets including the mitochondrial pyruvate carrier MPC1, alanine aminotransferase ALT2, endothelial eNOS, and mitochondrial translation/supercomplex programs [#19, #27, #16, #31]; it also enhances ERRγ transactivation via the receptor's AF-2 domain [#11]. Through PPARβ it transactivates a distal PPAR response element in the Ucp3 promoter to set oxidative capacity [#28], and it supports peroxisomal biogenesis in brown fat and hepatic gluconeogenic and bile-acid (CYP7A1) programs [#4, #3]. PGC-1α activity is set by an energy-sensing post-translational network: SIRT1 deacetylates it in an NAD+-dependent manner to selectively activate gluconeogenic (but not mitochondrial) genes, while protein abundance is controlled by EWS-dependent suppression of FBXW7-mediated ubiquitination and proteasomal degradation [#2, #15]. Beyond core metabolism, PGC-1α couples tissue physiology to its transcriptional outputs: it induces muscle FNDC5/irisin to drive adipose browning and, in hippocampus, BDNF expression [#5, #6], regulates VEGFA-dependent retinal angiogenesis [#14], promotes autophagy/mitophagy through SQSTM1 and the ULK1-ERRα axis [#22, #25], and controls extrasynaptic NMDAR activity and neuronal mitochondrial density [#13, #9]. Its expression is itself repressed by the Notch effector Hes1, linking it to fatty-acid-oxidation defects and kidney fibrosis [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the founding mechanism by which PGC-1α builds mitochondria — defining it as a coactivator that both induces and directly binds nuclear respiratory factors to drive the mtTFA-dependent mitochondrial gene program.\",\n      \"evidence\": \"Overexpression in muscle cells with promoter/binding assays and mitochondrial function readouts\",\n      \"pmids\": [\"10412986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map the post-translational signals that switch the coactivator on\", \"Tissue-specific selectivity of NRF coactivation not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined the human gene structure, chromosomal location, and broad tissue expression, framing PGC-1α as a metabolically active coactivator across energy-demanding organs.\",\n      \"evidence\": \"cDNA cloning, genomic organization, Northern blotting, chromosomal mapping\",\n      \"pmids\": [\"10585775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional or mechanistic data\", \"Isoform diversity not characterized\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed PGC-1α directly partners with the ERR family, identifying ERRγ as a coactivation target and mapping the receptor AF-2 domain requirement — a partnership that recurs across later metabolic programs.\",\n      \"evidence\": \"In vitro interaction, transfection reporter assays, receptor truncation mapping\",\n      \"pmids\": [\"12470660\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous gene targets of the PGC-1α–ERRγ pair not defined\", \"Single-lab in vitro context\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extended PGC-1α function into hepatic lipid/cholesterol catabolism by showing direct activation of the CYP7A1 promoter and bile-acid biosynthesis under fasting/diabetic conditions.\",\n      \"evidence\": \"Adenoviral overexpression in HepG2, promoter assays, bile-acid measurement, mouse models\",\n      \"pmids\": [\"14522988\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcription-factor intermediary on the CYP7A1 promoter not pinned down\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed how nutrient status tunes coactivator activity — SIRT1 NAD+-dependent deacetylation selectively activates the gluconeogenic but not the mitochondrial branch of PGC-1α output.\",\n      \"evidence\": \"Co-IP, in vitro deacetylation, adenoviral gain/loss-of-function, hepatic glucose output\",\n      \"pmids\": [\"15744310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Acetyl-lysine residues conferring program selectivity not fully resolved\", \"Counterbalancing acetyltransferase identity not addressed here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Tested whether PGC-1α drives gluconeogenesis through FOXO1 and showed FOXO1 is neither necessary nor sufficient, redefining their cooperation as indirect.\",\n      \"evidence\": \"G6Pase-luciferase reporter assays with FOXO1 gain/loss-of-function\",\n      \"pmids\": [\"17024043\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The actual direct factor mediating gluconeogenic activation left open\", \"Single reporter system\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated PGC-1α controls neuronal mitochondrial density and is the specific effector of SIRT1/GCN5 acetylation signaling in neurons, distinguishing its role from PGC-1β.\",\n      \"evidence\": \"Neuronal overexpression/shRNA epistasis, SIRT1 OE, GCN5 suppression, mitochondrial density\",\n      \"pmids\": [\"19542216\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream neuronal transcription factors not mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placed PGC-1α downstream of lipolysis-derived PPAR ligands in cardiac substrate oxidation, where its loss contributes to lethal cardiomyopathy rescued by PPARα agonism.\",\n      \"evidence\": \"ATGL knockout mice with PPARα agonist rescue, mitochondrial and cardiac function assays\",\n      \"pmids\": [\"21857651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct contribution of PGC-1α versus PGC-1β to the rescue not separated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected muscle PGC-1α to systemic endocrine signaling by identifying the FNDC5/irisin myokine that drives white-adipose browning and energy expenditure.\",\n      \"evidence\": \"Transgenic mice, cell culture, in vivo irisin treatment, metabolic measurement\",\n      \"pmids\": [\"22237023\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The adipocyte irisin receptor not identified in this work\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Expanded PGC-1α function to angiogenesis, showing it drives VEGFA expression required for retinal vessel development and pathological neovascularization.\",\n      \"evidence\": \"PGC-1α KO mice, oxygen-induced retinopathy, VEGFA expression, vascular morphometry\",\n      \"pmids\": [\"23141926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcription factor partner on the VEGFA promoter not defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified a neuroprotective role distinct from bioenergetics — PGC-1α restrains extrasynaptic NMDAR activity and excitotoxicity, with shared mechanism in Huntingtin pathology.\",\n      \"evidence\": \"RNAi/overexpression in primary neurons, electrophysiology, excitotoxicity and mHtt epistasis\",\n      \"pmids\": [\"22593067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular effector linking PGC-1α to NMDAR surface activity unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended the FNDC5/irisin axis to the brain, showing PGC-1α-dependent neuronal FNDC5 drives hippocampal BDNF expression.\",\n      \"evidence\": \"Pgc1a KO mice, primary neuron cultures, adenoviral OE, RNAi, gene expression\",\n      \"pmids\": [\"24120943\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which FNDC5 induces BDNF not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified IRF4 as a required transcriptional partner for the thermogenic UCP1 program, showing PGC-1α cannot drive thermogenesis without it.\",\n      \"evidence\": \"Reciprocal Co-IP, tissue-specific IRF4 KO/OE, energy expenditure and cold tolerance\",\n      \"pmids\": [\"24995979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the IRF4–PGC-1α interaction not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established proteostatic control of PGC-1α abundance — EWS stabilizes the protein by suppressing FBXW7-mediated ubiquitination and degradation.\",\n      \"evidence\": \"EWS KO cells/mice, ubiquitination and proteasome assays, FBXW7 knockdown rescue\",\n      \"pmids\": [\"25918410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Degradation-targeting phosphodegron on PGC-1α not mapped here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined an endothelial protective program in which ERRα-dependent PGC-1α drives eNOS expression to guard against hypertension.\",\n      \"evidence\": \"Endothelial-specific KO/TG mice, angiotensin II, eNOS and ERRα genetic/pharmacologic epistasis\",\n      \"pmids\": [\"27910955\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ERRα binding site on the eNOS gene not shown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed PGC-1α expression is directly repressed by the Notch effector Hes1, mechanistically linking its suppression to fatty-acid-oxidation defects and kidney fibrosis.\",\n      \"evidence\": \"ChIP for Hes1 on the PGC-1α regulatory region, Notch1 transgenic mice, rescue by PGC-1α OE\",\n      \"pmids\": [\"28751525\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors mediating Hes1 repression not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed a non-canonical nucleolar role for PGC-1α — it associates with rDNA and boosts RNA Pol I/UBF recruitment, coupling ribosomal to mitochondrial biogenesis.\",\n      \"evidence\": \"Subcellular fractionation, rDNA ChIP for Pol I and UBF, cell and mouse models\",\n      \"pmids\": [\"28819135\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signal directing PGC-1α to the nucleolus unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Mapped a direct PGC-1α–ERRα mechanism for mitochondrial pyruvate import via activation of the MPC1 promoter, required for pyruvate-dependent respiration.\",\n      \"evidence\": \"OE/siRNA, ERRα-response-element reporter, Co-IP, oxygen consumption with MPC inhibitor\",\n      \"pmids\": [\"29669911\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous ERRα occupancy at the MPC1 locus not shown by ChIP\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed the PGC-1α–ERRα pair controls amino-acid metabolism by transactivating the ALT2 promoter to drive fasting alanine production.\",\n      \"evidence\": \"OE/knockdown in C2C12, ALT2 promoter reporter, alanine measurement\",\n      \"pmids\": [\"29315328\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo confirmation of the muscle alanine program limited\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated PGC-1α/β increase muscle protein synthesis and myotube growth through ERRα, independently of the Akt/mTOR pathway.\",\n      \"evidence\": \"C2C12 OE with PI3K/mTOR inhibitors and ERRα siRNA, protein-synthesis and diameter readouts\",\n      \"pmids\": [\"30356878\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct translational targets downstream of ERRα not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked mutant p53 to PGC-1α in cancer, showing the codon 72 R72 variant enhances PGC-1α-driven mitochondrial function and metastatic capacity.\",\n      \"evidence\": \"Co-IP, migration/metastasis and mitochondrial assays, in vivo models\",\n      \"pmids\": [\"29463573\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of mutant-p53 modulation of PGC-1α activity not detailed\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the PGC-1α/PPARβ axis as the direct driver of Ucp3 via a distal PPAR response element, with UCP3 essential for PGC-1α-induced oxidative capacity.\",\n      \"evidence\": \"Quantitative ChIP on the Ucp3 promoter, OE, PPARβ/UCP3 knockdown, oxidative capacity\",\n      \"pmids\": [\"31228206\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which UCP3 supports oxidative capacity not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed PGC-1α sets the hepatic IRS1/IRS2 ratio downstream of glucagon/cAMP/CREB to control insulin-mediated suppression of gluconeogenesis.\",\n      \"evidence\": \"Reciprocal gain/loss-of-function in hepatocytes, ex vivo glucose production, in vivo OE\",\n      \"pmids\": [\"30770439\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CREB/PGC-1α occupancy at the IRS2 locus not shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified SQSTM1/p62 as a direct PGC-1α target driving vascular smooth muscle autophagy and limiting senescence.\",\n      \"evidence\": \"ppargc1a KO VSMCs, adenoviral OE, autophagy inhibitors, SQSTM1/ATG5 siRNA, EM, SA-β-gal\",\n      \"pmids\": [\"31441382\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter binding to SQSTM1 not demonstrated by ChIP\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed PGC-1α promotes fibroblast autophagy to enable TGFβ-driven myofibroblast differentiation and fibrosis, with pharmacological inhibition reversing established fibrosis.\",\n      \"evidence\": \"Fibroblast-specific KO mice, two fibrosis models, SR18292 inhibition, autophagy reporters\",\n      \"pmids\": [\"32482644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct autophagy gene targets in fibroblasts not enumerated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Distinguished PGC-1α isoform functions, showing isoform 4 uniquely drives anti-apoptotic programs in hepatocytes while canonical PGC-1α1 suppresses inflammatory networks.\",\n      \"evidence\": \"Isoform-specific gain/loss-of-function in hepatocytes, microarray, apoptosis assays, TNFα/LPS\",\n      \"pmids\": [\"32180561\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcription factor partners distinguishing isoform-specific programs not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed a developmental role in zebrafish, where ppargc1a drives ciliogenesis and ciliated-cell fate through prostaglandin (ptgs1/PGE2) signaling.\",\n      \"evidence\": \"Zebrafish KO with PGE2 and ptgs1 rescue/epistasis, cilia imaging, renal MCC fate\",\n      \"pmids\": [\"33176142\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mammalian conservation of the ciliogenic role not tested here\", \"Single lab, zebrafish model\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined a microglial PGC-1α–ERRα–ULK1 axis promoting autophagy/mitophagy that limits NLRP3 inflammasome activation after ischemic stroke.\",\n      \"evidence\": \"Microglia-specific TG mice, MCAO, ChIP-Seq, ULK1 inhibition/knockdown, NLRP3/autophagy readouts\",\n      \"pmids\": [\"33771213\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ERRα-dependent occupancy at ULK1 not isolated from ChIP-Seq\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Implicated PGC-1/PPAR signaling in cardiomyocyte maturation through previously unrecognized downstream proteins YAP1 and SF3B2, active in vivo but not in iPSC-derived cardiomyocytes.\",\n      \"evidence\": \"Single-cell transcriptomics, mosaic gene deletion, gene regulatory network analysis\",\n      \"pmids\": [\"33712605\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct regulatory relationships to YAP1/SF3B2 not biochemically established\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed PGC-1α with ERRα coordinates mitochondrial translation and supercomplex assembly, an axis impaired in sarcopenic muscle and restored by exercise.\",\n      \"evidence\": \"Mouse aging and exercise models, PGC-1α TG/KO, mitochondrial translation assays, ERRα interaction\",\n      \"pmids\": [\"37639610\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism coupling nuclear coactivation to mitochondrial translation not resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How distinct PGC-1α post-translational marks and isoforms are decoded into program-specific transcription factor recruitment — selecting gluconeogenic, mitochondrial, thermogenic, autophagic, or angiogenic outputs in a given cell — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking specific acetyl/phospho marks to specific transcription-factor partner engagement\", \"Genome-wide direct binding maps across tissues incomplete\", \"Structural basis of coactivator–receptor selectivity unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 3, 11, 16, 17, 19, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2, 17]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 2, 3, 19, 27, 28]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 11, 17, 28]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 4, 18]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [22, 23, 25]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ERRA\", \"ERRG\", \"SIRT1\", \"IRF4\", \"EWS\", \"FBXW7\", \"HES1\", \"TP53\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}